CAS 364782-34-3
:Cinacalcet hydrochloride
Description:
Cinacalcet hydrochloride is a synthetic compound primarily used as a medication to manage secondary hyperparathyroidism in patients with chronic kidney disease and to treat hypercalcemia in patients with parathyroid carcinoma. It functions as a calcimimetic agent, which means it enhances the sensitivity of calcium-sensing receptors on parathyroid cells, leading to decreased parathyroid hormone (PTH) secretion and subsequently lowering serum calcium levels. The substance is typically administered orally and is characterized by its white to off-white crystalline powder form. Its solubility profile indicates that it is soluble in water and methanol, which facilitates its absorption in the gastrointestinal tract. The molecular formula of cinacalcet hydrochloride reflects its complex structure, which includes multiple functional groups that contribute to its pharmacological activity. As with many medications, it is essential to monitor for potential side effects, including nausea, vomiting, and hypocalcemia, during treatment. Overall, cinacalcet hydrochloride plays a significant role in managing calcium homeostasis in specific patient populations.
Formula:C22H22F3N·ClH
InChI:InChI=1S/C22H22F3N.ClH/c1-16(20-13-5-10-18-9-2-3-12-21(18)20)26-14-6-8-17-7-4-11-19(15-17)22(23,24)25;/h2-5,7,9-13,15-16,26H,6,8,14H2,1H3;1H/t16-;/m1./s1
InChI key:InChIKey=QANQWUQOEJZMLL-PKLMIRHRSA-N
SMILES:[C@@H](NCCCC1=CC(C(F)(F)F)=CC=C1)(C)C=2C3=C(C=CC2)C=CC=C3.Cl
Synonyms:- 1-Naphthalenemethanamine, α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-, hydrochloride (1:1), (αR)-
- 1-Naphthalenemethanamine, α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-, hydrochloride, (αR)-
- AMG 073 HCl
- Cinacalcet HCl
- Krn 1493
- Mimpara
- N-((1R)-1-(1-Naphthyl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine hydrochloride
- Regpara
- Sensipar
- [(1R)-1-(Naphthalen-1-yl)ethyl]([3-[3-(trifluoromethyl)phenyl]propyl])amine hydrochloride
- Cinacalcet hydrochloride
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 13 products.
Cinacalcet Hydrochloride
CAS:Formula:C22H22F3N·HClPurity:>98.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:393.88Cinacalcet Hydrochloride (N-[(1R)-1-(Naphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride)
CAS:Aromatic monoamines and their derivatives, salts thereof, nesoiFormula:C22H22F3N·HClColor and Shape:White Off-White Crystalline PowderMolecular weight:393.14711Cinacalcet hydrochloride
CAS:Cinacalcet hydrochlorideFormula:C22H22F3N·ClHPurity:99%Color and Shape: white solidMolecular weight:393.87g/molCinacalcet HCl
CAS:Formula:C22H22F3N·HClColor and Shape:White To Off-White SolidMolecular weight:357.42 36.46Cinacalcet Hydrochloride
CAS:Controlled ProductFormula:C22H22F3N·ClHColor and Shape:NeatMolecular weight:393.87Cinacalcet hydrochloride
CAS:<p>Cinacalcet hydrochloride (AMG-073 hydrochloride) is a naphthalene derivative and CALCIMIMETIC AGENT that increases the sensitivity of PARATHYROID GLAND calcium-</p>Formula:C22H23ClF3NPurity:99.96% - >99.99%Color and Shape:Off-White To Tan SolidMolecular weight:393.87Cinacalcet-d4 Hydrochloride
CAS:Controlled Product<p>Applications Cinacalcet-d4 Hydrochloride is a labeled analogue of Cinacalcet Hydrochloride (C441800), the (R) enantiomer of Cinacalcet which is used in clinical trial in secondary hyperparathyroidism.<br>References Franceschini N., et al.: Expert Opin. Invest. Drugs, 12, 1413 (2003); Block, G.A., et al.: N. Engl. J. Med. 350, 1516 (2004);<br></p>Formula:C22H19D4ClF3NColor and Shape:NeatMolecular weight:397.9Cinacalcet Hydrochloride
CAS:Controlled ProductFormula:C22H22F3N·ClHColor and Shape:White To BeigeMolecular weight:393.87N-[1-(R)-(-)-(1-Naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]-1-aminopropane hydrochloride
CAS:<p>N-[1-(R)-(-)-(1-Naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]-1-aminopropane hydrochloride is a synthetic compound that is used for the treatment of hyperparathyroidism. It inhibits parathyroid hormone (PTH) synthesis by inhibiting the enzyme responsible for PTH synthesis, which is called adenyl cyclase. This drug also binds to calcium ions and inhibits their release from bones and teeth. N-[1-(R)-(-)-(1-Naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]-1-aminopropane hydrochloride has been shown to be effective in treating skin cancer in animal models. It has also been shown to have a reaction mechanism in which it binds to DNA, preventing transcription and replication through inhibition of RNA polymerase. The clinical significance of this drug as a potential biomark</p>Formula:C22H22F3N·HClPurity:Min. 95%Color and Shape:White PowderMolecular weight:393.87 g/mol(R)-N-(1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine hydrochloride
CAS:Formula:C22H23ClF3NPurity:97.0%Color and Shape:SolidMolecular weight:393.88











